BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2019
View Archived Issues
LNC helps TNBC go AWOL
Read More
Gilead initiates phase I study of GS-1423 in advanced solid tumors
Read More
Inhibiting CCL24 with CM-101 reduces fibrosis and inflammation in systemic sclerosis
Read More
Luspatercept MOA: Up for grabs?
Read More
Increased clotting contributes to cardiovascular risk in HIV-infected individuals
Read More
Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists
Read More
Collaborative Medicinal Development describes ferroptosis inhibitors
Read More
New PPAR agonists identified at Sichuan Kelun-Biotech Biopharmaceutical
Read More
Positive 6-month results from phase II open-label study of ATI-502 in androgenetic alopecia
Read More
Regeneron Pharmaceuticals initiates phase II study of REGN-5069 in osteoarthritis of the knee
Read More
Ribomic presents positive topline results from phase I/IIa SUSHI study of RBM-007 in wet AMD
Read More
Avelumab plus axitinib combination demonstrates antitumor activity in first-line HCC
Read More
Phase I results for venetoclax plus high-dose cytarabine in children with relapsed/refractory AML
Read More
New PRMT5 inhibitors presented by Jubilant Biosys
Read More
Kyoto Pharmaceutical Industries discovers albumin-binding prodrugs
Read More
CB-5064 analogues for weight and fat loss tested in vitro and in vivo
Read More
Netakimab safe and effective in spondyloarthritis: data from the phase III ASTERA trial
Read More
Repeat dosing of KZR-616 is well tolerated in patients with systemic lupus erythematosus
Read More
RNF213 gene variant found to cause pulmonary arterial hypertension with poor prognosis
Read More
Xeris reports promising data from phase III study of ready-to-use glucagon
Read More
FDA approves Victoza for type 2 diabetes in children and adolescents
Read More
BI-765063 begins first-in-human study in advanced solid tumors
Read More
CRV-431 decreases fibrosis and key biomarkers of liver disease in experimental model
Read More
PB-2452 reverses ticagrelor antiplatelet activity in older and elderly patients in phase IIa trial
Read More
European approval of Lynparza as first-line maintenance treatment for BRCAm advanced ovarian cancer
Read More
Rozlytrek approved in Japan for NTRK fusion-positive, advanced recurrent solid tumors
Read More